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Abstract The aim of the present study was to examine the
in-depth application of the Short-Form-(SF)-36 Health
Survey to score the general well-being in fibromyalgia
syndrome (FS) patients. Quality of life was evaluated in 12
patients with FS. With respect to mental well-being (social
functioning, role limitation due to emotional health problems,
and mental health), two distinguished groups were found
concerning psychological functioning. One group (n = 8)
demonstrated psychological dysfunction, whereas the other
(n = 4) showed normal psychological scores. Physical well-
being scores (physical functioning, role limitation due to
physical health problems, bodily pain, general health, and
vitality) did not differ between FS patients but were
altogether below the normal range. Regarding the psycho-
logical scores of the two groups of patients, SF-36 can be
used to differentiate between patients with and without
psychological dysfunction independent of pain. Therefore,
we propose that the SF-36 could be of help to provide the
most adequate therapy to achieve an optimal outcome in
patients with FS and psychological disturbances.
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Introduction
Fibromyalgia syndrome (FS) is a chronic widespread pain
condition that affects 1–4% of the population and is
characterized by diffuse pain in the absence of synovitis or
myositis [1]. The musculoskeletal examination is unremark-
able except for tenderness upon palpation of discrete
anatomical locations termed tender points [2]. Associated
symptoms include sleep disturbance, fatigue, irritable bowel
syndrome, cognitive disturbances, and mood disorders [1].
The patients who fulfill the classification criteria of the
American College of Rheumatology (ACR) for the diag-
nosis of FS [3] are not a homogenous group. It has been
postulated that FS is not a distinct clinical entity [4]. There
are different subgroups of primary FS. At least three
different subgroups have been described: one group with
high pain sensitivity without any associated psychological/
cognitive factors, a second group which displays moderate
tenderness and normal mental well-being, and a third group
in which psychological/cognitive factors may play a major
role in pain manifestation [4, 5]. There is also growing
evidence for a substantial lifetime psychiatric comorbidity
in individuals with FS [6].
Assessment of patients with FS should therefore not only
focus on myofascial pain and the search for the tender
points but also on concomitant affective disorders. Consid-
ering distinct subgroups, one might be able to provide the
patients with an adequate individual therapy.
While postulating different subgroups of FS with possible
psychiatric comorbidity, an easily applied instrument for the
differentiation between individuals with and without affective
distress needs to be found. Subjective information has proven
to be a useful tool in the assessment of rheumatoid arthritis
patients [7, 8] as well as in FS patients [9]. Birtane et al. [10]
found in their study, using SF-36, that patients with FS are
more severely affected in mental health when compared to
patients with rheumatoid arthritis. The SF-36 is providing
information on patients’ physical, functional, emotional, and
social well-being. Whether using SF-36 helps to distinguish
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between patients with and without affective disorders needs
to be investigated. We therefore test the hypothesis that SF-
36 is a tool to select patients with FS in need of specialized
psychological therapy.
Materials and methods
Patient selection
The study was performed in FS patients who presented at
the Department of Rheumatology, University Hospital of
Zurich, Switzerland. The diagnosis of FS was made
according to the ACR classification criteria available for
the disease [3]. Twelve patients were prospectively included
during the study period. The patients were of sufficient
intellectual capacity to fill out the SF-36 and they need to
give informed consent to participate in the study. Patients
underwent a complete physical examination and specific
consultations when needed. Patients with additional sys-
temic health disorders, which may have the potential to
influence the functional capacity of the patients, were not
included in the study. Before the performance of physical
examination, demographic characteristics, such as age,
gender, height, and weight, and social parameters, such as
employment, educational, economical, and marital status of
the study participants, were noted.
Measurements
Health Survey Questionnaire (SF-36)
The SF-36 was used to evaluate the quality of life of each
FS subject and to distinguish FS patients with and without
emotional impairment [11]. All the patients with FS
completed the SF-36 questionnaire at the time of their
clinical evaluation. The SF-36 consists of 36 items that are
employed to calculate scores on eight dimensions: physical
functioning, role limitation due to physical health problems,
bodily pain, general health, vitality, social functioning, role
limitation due to emotional health problems, and mental
health. Scores range from 0 to 100, with a higher score
indicating a better health-related quality of life. The SF-36
questionnaire data are presented as graphs (Fig. 1).
Results
In analyzing our data, we found two different groups of
patients with FS in terms of psychological well-being
independent of pain intensity (Fig. 1). Patients with values
below 50 were considered as patients with emotional
problems. Black bars show an example of the general health
of the patients with emotional problems and pain (n=8),
which were showing extensively reduced emotional role, and
white bars present patients (n=4) with good emotional role
and pain. Both groups showed similar physical dysfunction.
Regarding role limitation due to emotional health problems,
mental health, and social functioning, the data demonstrated
dysfunction in one distinct group. The physical function,
bodily pain, and vitality parameters were reduced in both the
subgroups compared to control group of age-matched US
healthy women (line).
Discussion
Pain and depression may affect the daily life and functional
activities of the FM patients, which can be measured by the
SF-36. Our study compared the quality of life of 12 twelve
patients with FS. Analyzing the scores of the SF-36, we
found differences in both emotional and mental health and
social functioning. These findings help to confirm the
clinical suspicion of different subgroups of patients with
FS. While one group scored normal psychological results,
the other showed psychological dysfunction. Differentiating
the latter subgroup based on responses to the Multidimen-
sional Pain Inventory study by Thieme et al. [1, 12], nearly
75% of the patients with FS exhibited anxiety and mood
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Fig. 1 Health survey questionnaire (SF-36) score of fibromyalgia
patients with and without disturbed “role emotional.” White bars
represent the general health score of the patients with normal
emotional status. Black bars show the general health of the patients
with reduced emotional role. The line represents healthy female
reference population [11] in the same age range as the patients. 0 Most
severe failure, 100 most healthy state. Means are given
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disorders. Arnold et al. [13] found heightened incidence of
FS combined with major mood disorders in families. The
high degree of familial aggregation found in the study of
Arnold et al. could not be plausibly explained in the
absence of genetic factors [14, 15].
The results of our study suggest that the SF-36 allows a
differentiation of subgroups in FS patients in terms of
psychological impairment. Observing the role limitation
due to emotional health problems, a clear separation of
patients with mood disorders can be seen. Using just one
dimension of the SF-36, this differentiation of the sub-
groups is possible. Therefore, we conclude that patients
with a negative score on role limitation due to emotional
health problems need to be treated against psychological
dysfunction assuming that there is a mood disorder.
Postulating different subgroups in patients with FS, the
application of multimodal individualized treatment pro-
grams needs consideration in the multifaceted nature of FS.
Therefore, examination of FS patients should not only
include the search for the tender points but also for the
presence of affective disorders. Treatment should aim at
physical and emotional well-being. Because of the small
number of patients in our study, statistical analysis was not
performed. However, the results suggest how important the
consideration of the mental health in FS patients may be in
regard to their individual therapy regime.
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